The usefulness and Safety of propofol for benzodiazepine resistance cases in endoscopic sedation

The usefulness and Safety of propofol for benzodiazepine resistance cases in endoscopic sedation - Propofol for benzodiazepine resistance cases in endoscopic sedation

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

JPRN

Registry ID

JPRN-UMIN000017076

Enrollment

120

Registered

2015-04-08

Start date

2015-04-08

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Disease that requires endoscopic procedures

Interventions

We use propofol, if midazolam is insufficient in sedation.

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: 1.Endoscopy procedures that required sedation. 2.More than 20 years of age. 3.ECOG Performance Status is 0 or 1. 4.There is no severe liver or kidney dysfunction. 5.No contraindication for propofol. 6.Have been obtained the consent of the study participants in the document.

Exclusion criteria

Exclusion criteria: 1. Hypersensitivity history to propofol or formulation. 2. During pregnancy, during lactation. 3. ECOG-Performance Status is over 2 or more. 4. Advanced liver of kidney dysfunction. 5. Determined to be inappropriate to carry out the study.

Design outcomes

Primary

Measure	Time frame
Adverse events and safety in using propofol	—

Countries

Japan

Contacts

Public ContactTomoyuki Hayashi

Kanazawa University Hospital Department of Gastroenterology

hayasix0917@gmail.com076-265-2235

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026